TY  - CHAP
M1  - Book, Section
TI  - Non–Small Cell Lung Cancer Treatment: Metastatic
A1  - van Berkel, Victor
A1  - Cudris, Jennifer
A1  - Dunlap, Neal E.
A1  - Gil-Bazo, Ignacio
A1  - Mandish, Steven
A1  - Marino, Katy Alyse
A1  - Ngo, Phuong T.
A1  - Perez, Cesar A.
A1  - Llerena, Jose Pinto
A1  - Santos, Edgardo S.
A1  - Tumen, Andrew
A1  - Turquie, Moises Harari
A2  - Kloecker, Goetz
A2  - Arnold, Susanne M.
A2  - Fraig, Mostafa M.
A2  - Perez, Cesar A.
PY  - 2021
T2  - Lung Cancer: Standards of Care
AB  - Learning  ObjectivesWhat  is  oligometastatic  non–small  cell  lung  cancer  (NSCLC)?What  clinicopathological  features  are  suggestive  of  oligometastatic  disease?How  does  the  eighth  edition  of  the  TNM  (tumor,  node,  metastasis)  staging  system  account  for  this  concept?How  can  the  clinician  determine  whether  2  foci  of  lung  cancer  represent  metastatic  disease  or  independent  primary  tumors?What  is  the  ideal  treatment  approach  and  extent  of  resection  in  this  subgroup  of  patients?  
SN  - 
PB  - McGraw-Hill
CY  - New York, NY
Y2  - 2024/04/19
UR  - hemonc.mhmedical.com/content.aspx?aid=1176020413
ER  -